MWA
BNGO icon

Medallion Wealth Advisors’s Bionano Genomics BNGO Stock Holding History

Medallion Wealth Advisors’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1 Hold
1
– – ﹤0.01% 1219
2026
Q1 		$1 Hold
1
– – ﹤0.01% 1121
2025
Q4 		$2 Hold
1
– – ﹤0.01% 1119
2025
Q3 		$2 Hold
1
– – ﹤0.01% 1103
2025
Q2 		$3 Hold
1
– – ﹤0.01% 1096
2025
Q1 		$3 Hold
1
– – ﹤0.01% 1074
2024
Q4 		$25 Buy
+1
New +$17 ﹤0.01% 1011

Other funds holding BNGO

GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
CAM
Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Fiduciary Trust
Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Prudential Financial
Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Medallion Wealth Advisors's BNGO Position: Q2 2026 in Review

Medallion Wealth Advisors held its Bionano Genomics (BNGO) position steady in Q2 2026 at 1 share worth $1. The position accounts for ﹤0.01% of the portfolio, ranked #1219.

Medallion Wealth Advisors first reported a position in BNGO in Q4 2024 and has held it in 7 quarters since. The position peaked at $25 in Q4 2024. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

  • Medallion Wealth Advisors held 1 share of Bionano Genomics worth $1 as of Q2 2026.
  • Medallion Wealth Advisors left its Bionano Genomics share count unchanged in Q2 2026.
  • Bionano Genomics made up ﹤0.01% of Medallion Wealth Advisors's portfolio in Q2 2026, its #1219 holding.
  • Medallion Wealth Advisors first reported a position in Bionano Genomics in Q4 2024 and has held it in 7 quarters since.
  • Medallion Wealth Advisors's Bionano Genomics position peaked at $25 in Q4 2024.
  • 34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Medallion Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.